ES8100880A1 - Procedimiento para la fabricacion de una forma de accion re-tardada mejorada. - Google Patents
Procedimiento para la fabricacion de una forma de accion re-tardada mejorada.Info
- Publication number
- ES8100880A1 ES8100880A1 ES482496A ES482496A ES8100880A1 ES 8100880 A1 ES8100880 A1 ES 8100880A1 ES 482496 A ES482496 A ES 482496A ES 482496 A ES482496 A ES 482496A ES 8100880 A1 ES8100880 A1 ES 8100880A1
- Authority
- ES
- Spain
- Prior art keywords
- core
- water
- coating
- contain
- active substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000011248 coating agent Substances 0.000 abstract 3
- 238000000576 coating method Methods 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Substances OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 2
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 abstract 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract 1
- 239000001856 Ethyl cellulose Substances 0.000 abstract 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 abstract 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 230000036765 blood level Effects 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 229920002301 cellulose acetate Polymers 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 235000019325 ethyl cellulose Nutrition 0.000 abstract 1
- 229920001249 ethyl cellulose Polymers 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 229920000609 methyl cellulose Polymers 0.000 abstract 1
- 239000001923 methylcellulose Substances 0.000 abstract 1
- 235000010981 methylcellulose Nutrition 0.000 abstract 1
- 235000013348 organic food Nutrition 0.000 abstract 1
- 230000035699 permeability Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000011975 tartaric acid Substances 0.000 abstract 1
- 235000002906 tartaric acid Nutrition 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 229920003169 water-soluble polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Un procedimiento para la fabricación de composiciones de fórmula de cemento Sorel que contienen cloruro de magnesio, óxido de magnesio, agua y una cantidad nucleante de una fórmula de premezcla, que comprende mezclar cloruro de magnesio, óxido de magnesio, agua y una cantidad nucleante de una composición de premezcla que incluye el producto de reacción de agua, cloruro de magnesio y una cantidad relativamente pequeña de óxido de magnesio para proporcionar una composición de cemento Sorel y después de curar dicha composición.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19782831164 DE2831164A1 (de) | 1978-07-15 | 1978-07-15 | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8100880A1 true ES8100880A1 (es) | 1980-12-01 |
| ES482496A0 ES482496A0 (es) | 1980-12-01 |
Family
ID=6044470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES482496A Granted ES482496A0 (es) | 1978-07-15 | 1979-07-14 | Procedimiento para la fabricacion de una forma de accion re-tardada mejorada. |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPS5519257A (es) |
| DE (1) | DE2831164A1 (es) |
| ES (1) | ES482496A0 (es) |
| HU (1) | HU179935B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6082131A (ja) * | 1983-10-12 | 1985-05-10 | Nagoya Yukagaku Kogyo Kk | フェノール樹脂用微小カプセル型硬化剤 |
| JPH0776172B2 (ja) * | 1986-04-16 | 1995-08-16 | 藤沢薬品工業株式会社 | マトリツクス錠 |
| US20030175349A1 (en) * | 2001-01-30 | 2003-09-18 | Council Of Scientific And Industrial Research | Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient |
| BG860Y1 (bg) * | 2004-09-17 | 2007-02-28 | "Софарма" Ад | Лекарствена форма на дипиридамол |
| US20070184110A1 (en) * | 2006-02-09 | 2007-08-09 | Minutza Leibovici | Dipyridamole extended-release formulations and process for preparing same |
-
1978
- 1978-07-15 DE DE19782831164 patent/DE2831164A1/de not_active Withdrawn
-
1979
- 1979-07-13 JP JP8917779A patent/JPS5519257A/ja active Pending
- 1979-07-13 HU HUBO001797 patent/HU179935B/hu unknown
- 1979-07-14 ES ES482496A patent/ES482496A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE2831164A1 (de) | 1980-01-24 |
| JPS5519257A (en) | 1980-02-09 |
| ES482496A0 (es) | 1980-12-01 |
| HU179935B (en) | 1983-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8404467D0 (sv) | Controlled-release medical preparations | |
| GB1465781A (en) | Pharmaceutical preparations | |
| ATE8459T1 (de) | Pharmazeutische zubereitung in form eines polyacrylatfilmes und deren herstellung. | |
| NO884947L (no) | Fremgangsmaate for fremstilling av farmasoeytisk doseringsform med kontrollert frigjoerelse. | |
| ATE43497T1 (de) | Pharmazeutische formulierung mit gesteuerter absorption. | |
| DE69002604D1 (de) | Pharmazeutische zubereitung mit verzoegerter freisetzung und seine herstellung. | |
| NO162103C (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat | |
| DE69106501D1 (de) | Osmotisches dosiersystem zur verabreichung von flüssigen arzneimitteln. | |
| DK236388D0 (da) | Mikrogranulaert praeparat, der er anvendeligt til frigoerelse af biologisk aktive materialer i tarmregionerne hos dyr | |
| SE8300577D0 (sv) | Overdrag som tillforsekrar reglerad avgivning av akriva bestandsdelar fran biologiskt aktiva blandningar, i synnerhet farmaceutiska beredningar, jemte sett att framstella biologiskt aktiva blandningar med reglerad .... | |
| SE8803822D0 (sv) | Novel dosage form | |
| ATE34300T1 (de) | Theophyllin mit verlaengerter abgabe. | |
| ES8100880A1 (es) | Procedimiento para la fabricacion de una forma de accion re-tardada mejorada. | |
| ES8105145A1 (es) | Un procedimiento para la preparacion de una composicion de liberacion controlada de un compuesto biologicamente activo para su administracion a un animal | |
| JPS5679622A (en) | Antitumor pharmaceutical | |
| JPS5583710A (en) | Spongy enzyme preparation | |
| CS185652B2 (en) | Insecticide and acaricide agent and mode of manufacture of active substance | |
| ES247237A1 (es) | UN MÉTODO PARA LA PREPARACION DE GRáNULOS DE ACCIoN PROLONGADA | |
| ATE9957T1 (de) | Verfahren zur herstellung eines umhuellten acetylsalicylsaeurepraeparates. | |
| JPS579711A (en) | Preparation of prolonged release type complex | |
| JPS57142913A (en) | Donor of physiologically active substance | |
| JPS53139716A (en) | Pharmaceutical preparation of stable prostaglandine | |
| IT1214658B (it) | Esteri polisaccaridici e loro sali | |
| KR910015297A (ko) | 오메프라졸 경구용 약제와 그 제조방법 | |
| JPS643123A (en) | Remedy for skin inflammation |